NCR1 Antibody Blocking Peptide(bs-21362P)-500ug

NCR1 Antibody Blocking Peptide

(bs-21362P)-500ug
收藏
  • ¥880
  • Bioss已认证
  • bs-21362P
  • 2025年10月16日
    avatar
    品牌商
    9钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 规格

      500ug

    产品编号bs-21362P
    英文名称NCR1 Antibody Blocking Peptide
    中文名称细胞毒性受体NK-p46封闭多肽
    英文别名Natural killer cell p46-related protein; Natural cytotoxicity triggering receptor 1; NK-p46; NKp46; NK cell-activating receptor; Lymphocyte antigen 94 homolog; CD335; CD 335; LY94; NCTR1_HUMAN.
    纯化方法HPLC
    研究领域

    Immunology > Adaptive Immunity > T Cells > Cytotoxic Cells

    Signal Transduction > Adapters > Transmembrane

    亚基Interacts with CD247 and FCER1G
    亚细胞定位Cell membrane.
    组织特异性Selectively expressed by both resting and activated NK cells.
    翻译后修饰N-glycosylated.
    O-glycosylated.
    相似性Belongs to the natural cytotoxicity receptor (NCR) family.
    Contains 2 Ig-like (immunoglobulin-like) domains.
    功能Cytotoxicity-activating receptor that may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis.
    保存条件Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.
    注意事项This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    背景资料The natural cytotoxicity receptors (NCRs) are a recently characterized family of Ig-like activation receptors that appear to be major triggering receptors in tumor cell recognition. NCR1 is a glycoprotein that has two extracellular Ig-like domains followed by a ~40 amino acid residue stalk region, a type I transmembrane domain, and a short cytoplasmic tail. NCR1 has been shown to represent a novel NK cell-specific molecule involved in human NK cell activation. NCR1 has been implicated in NK cell-mediated lysis of several autologous tumor cells and pathogen-infected cell lines.

     

     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥880
    北京博奥森生物技术有限公司
    2025年10月16日询价
    ¥1536
    武汉博欧特生物科技有限公司
    2025年05月22日询价
    ¥720
    上海经科化学科技有限公司
    2025年10月27日询价
    ¥1759.50
    深圳欣博盛生物科技有限公司
    2025年07月16日询价
    ¥3784.50
    西宝生物科技(上海)股份有限公司
    2025年07月04日询价
    NCR1 Antibody Blocking Peptide(bs-21362P)-500ug
    ¥880